1. Blood pressure should be measured in individuals with diabetes at every hospital visit. [Expert opinion, general recommendation]

2. Home blood pressure monitoring is recommended for individuals with diabetes and hypertension. [Randomized controlled trial, general recommendation]

3. It is recommended that individuals with diabetes but without CVDs or risk factors maintain their blood pressure level at <140/90 mm Hg. [Randomized controlled trial, general recommendation]

4. Individuals with diabetes with CVD, end-organ damage (albuminuria, CKD, retinopathy, left ventricular hypertrophy), or risk factors for CVD should maintain their blood pressure at <130/80 mm Hg. [Randomized controlled trial, general recommendation]

5. Individuals with diabetes and blood pressure ≥120/80 mm Hg should change their lifestyle, including weight control, appropriate exercise, and dietary management, to maintain normal blood pressure. [Randomized controlled trial, general recommendation]

6. Every antihypertensive agent can be used for individuals with diabetes and hypertension as the first-line therapy. [Randomized controlled trial, general recommendation]

7. Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs) are recommended first-line therapy for individuals with diabetes and albuminuria as antihypertensive agents. [Randomized controlled trial, general recommendation]

8. ACE inhibitors or ARBs are recommended first-line therapy for individuals with diabetes and coronary artery diseases as antihypertensive agents. [Randomized controlled trial, general recommendation]

9. If the blood pressure level is not controlled with first-line therapy, a combination therapy using drugs with a different mechanism of action should be employed. However, a combination of ACE inhibitors and ARBs should not be used. [Randomized controlled trial, general recommendation]

10. If blood pressure exceeds 160/100 mm Hg, lifestyle should be corrected aggressively, and a combination of two or more medications should be initiated. [Randomized controlled trial, general recommendation]